Loading...
Regulatory considerations for clinical development of cancer vaccines
Cancer vaccines are aimed at stimulating an immune response to tumor tissue. There is a high level of clinical activity in this rapidly advancing field with over 1,400 trials registered on Clincaltrials.gov. The recent approval of Sipuleucel-T which is the first cancer vaccine approved in the US and...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514046/ https://ncbi.nlm.nih.gov/pubmed/25625933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.982999 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|